For: | Coppola N, Onorato L, Minichini C, Di Caprio G, Starace M, Sagnelli C, Sagnelli E. Clinical significance of hepatitis B surface antigen mutants. World J Hepatol 2015; 7(27): 2729-2739 [PMID: 26644816 DOI: 10.4254/wjh.v7.i27.2729] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i27/2729.htm |
Number | Citing Articles |
1 |
Samaneh Karimkhanilouyi, Saeid Ghorbian. Nucleic acid vaccines for hepatitis B and C virus. Infection, Genetics and Evolution 2019; 75: 103968 doi: 10.1016/j.meegid.2019.103968
|
2 |
Brice Malve, Marine Eschlimann, Shaunagh Galgey, Honorine Fenaux, Fabien Zoulim, François Goehringer, Christian Rabaud, Thierry May, Hélène Jeulin, Evelyne Schvoerer. Impact of deletions and mutations in Hepatitis B virus envelope proteins on serological profile and clinical evolution. Virus Research 2017; 238: 141 doi: 10.1016/j.virusres.2017.06.028
|
3 |
Nidaa A. Ababneh, Malik Sallam, Doaa Kaddomi, Abdelrahman M. Attili, Isam Bsisu, Nadia Khamees, Amer Khatib, Azmi Mahafzah. Patterns of hepatitis B virusSgene escape mutants and reverse transcriptase mutations among genotype D isolates in Jordan. PeerJ 2019; 7: e6583 doi: 10.7717/peerj.6583
|
4 |
Jamil N. Kanji, Robert E.D. Penner, Elizabeth Giles, Karin Goodison, Steven R. Martin, Eric Marinier, Carla Osiowy. Horizontal Transmission of Hepatitis B Virus From Mother to Child Due to Immune Escape Despite Immunoprophylaxis. Journal of Pediatric Gastroenterology and Nutrition 2019; 68(5) doi: 10.1097/MPG.0000000000002318
|
5 |
Ann Mathew, Nalia Ismael, Heidi Meeds, Adolfo Vubil, Ana Flora Zicai, Nédio Mabunda, Jason T. Blackard, Pierre Roques. Hepatitis B virus genotypes and drug resistance mutations circulating in blood donors in Beira, Mozambique. PLOS ONE 2023; 18(2): e0281855 doi: 10.1371/journal.pone.0281855
|
6 |
Hrvoje Mijočević, Hadi Karimzadeh, Judith Seebach, Zainab Usman, Mamun Al‐Mahtab, Michel Bazinet, Andrew Vaillant, Michael Roggendorf. Variants of hepatitis B virus surface antigen observed during therapy with nucleic acid polymer REP 2139‐Ca have no influence on treatment outcome and its detection by diagnostic assays. Journal of Viral Hepatitis 2019; 26(4): 485 doi: 10.1111/jvh.13044
|
7 |
Rafael Sanjuán, Pilar Domingo-Calap. Mechanisms of viral mutation. Cellular and Molecular Life Sciences 2016; 73(23): 4433 doi: 10.1007/s00018-016-2299-6
|
8 |
Yaoyue Kang, Fahong Li, Hongying Guo, Sisi Yang, Yongmei Zhang, Haoxiang Zhu, Jinyu Wang, Richeng Mao, Yanli Qin, Jie Xu, Xinwen Chen, Chunchen Wu, Jiming Zhang. Amino acid substitutions Q129N and T131N/M133T in hepatitis B surface antigen (HBsAg) interfere with the immunogenicity of the corresponding HBsAg or viral replication ability. Virus Research 2018; 257: 33 doi: 10.1016/j.virusres.2018.08.019
|
9 |
Lung-Yi Mak, Wai-Kay Seto, James Fung, Man-Fung Yuen. Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B. Hepatology International 2020; 14(1): 35 doi: 10.1007/s12072-019-09998-5
|
10 |
Chun-Chen Wu, Ying-Shan Chen, Liang Cao, Xin-Wen Chen, Meng-Ji Lu. Hepatitis B virus infection: Defective surface antigen expression and pathogenesis. World Journal of Gastroenterology 2018; 24(31): 3488-3499 doi: 10.3748/wjg.v24.i31.3488
|
11 |
Nicola Coppola, Lorenzo Onorato, Valentina Iodice, Mario Starace, Carmine Minichini, Nunzia Farella, Giulia Liorre, Pietro Filippini, Evangelista Sagnelli, Giorgio de Stefano. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study. Oncotarget 2016; 7(38): 62706 doi: 10.18632/oncotarget.10909
|
12 |
Francisca Sosa-Jurado, Virginia Sedeño-Monge, Luis Márquez-Domínguez, Paulina Cortés-Hernández, Verónica Vallejo-Ruiz, Gerardo Santos-López. Pathogens Associated with the Development of Cancer in Humans. 2024; : 45 doi: 10.1007/978-3-031-62558-9_3
|
13 |
Xingxin Zhang, Chenjian Gu, Qian Wei, Yirong Cao, Weimin She, Hong Shi, Youhua Xie, Jinsheng Guo. Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients. Journal of Hepatocellular Carcinoma 2023; : 599 doi: 10.2147/JHC.S373333
|
14 |
Federico A. Di Lello, Ezequiel Ridruejo, Alfredo P. Martínez, Paula S. Pérez, Rodolfo H. Campos, Diego M. Flichman. Molecular epidemiology of hepatitis B virus mutants associated with vaccine escape, drug resistance and diagnosis failure. Journal of Viral Hepatitis 2019; 26(5): 552 doi: 10.1111/jvh.13052
|
15 |
David A. Kennedy, Andrew F. Read. Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance. Proceedings of the National Academy of Sciences 2018; 115(51): 12878 doi: 10.1073/pnas.1717159115
|
16 |
Julian Musa, Jing Li, Thomas GP Grünewald. Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failure. The Journal of Pathology 2019; 247(1): 6 doi: 10.1002/path.5169
|
17 |
Vanja Ničković, Radoslav Katanić, Nataša Katanić, Ilija Kocić. CHRONIC HEPATITIS B. Acta Medica Medianae 2017; 56(4): 50 doi: 10.5633/amm.2017.0408
|
18 |
Shu-Xiang Wu, Shuang-Shuang Ye, Yu-Xiang Hong, Yan Chen, Biao Wang, Xin-Jian Lin, Xu Lin, J.-H. James Ou. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A. Journal of Virology 2022; 96(4) doi: 10.1128/jvi.01975-21
|
19 |
Davod Javanmard, Mohammad Hasan Namaei, Mohammad Farahmand, Arash Ziaee, Elham Amini, Masood Ziaee. Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia. Journal of Medical Virology 2019; 91(8): 1519 doi: 10.1002/jmv.25470
|
20 |
Li-Bo Yan, Xia Zhu, Lang Bai, Xiao-Qiong Tang, Ling-Yao Du, En-Qiang Chen, Ling-Bo Liang, Hong Tang. Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B. Clinics and Research in Hepatology and Gastroenterology 2017; 41(3): 296 doi: 10.1016/j.clinre.2016.11.003
|
21 |
Marina Bubonja-Šonje, Dolores Peruč, Maja Abram, Bojana Mohar-Vitezić. Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia. Annals of Hepatology 2024; 29(1): 101156 doi: 10.1016/j.aohep.2023.101156
|
22 |
Hyon Suk Kim, Xinyue Chen, Min Xu, Cunling Yan, Yali Liu, Haohui Deng, Bui Huu Hoang, Pham Thi Thu Thuy, Terry Wang, Yiwen Yan, Zhen Zeng, Mikael Gencay, Gaston Westergaard, Stephan Pabinger, Albert Kriegner, Markus Nauck, Anja Seffner, Peter Gohl, Kirsten Hübner, Wolfgang E. Kaminski. Frequency of hepatitis B surface antigen variants (HBsAg) in hepatitis B virus genotype B and C infected East- and Southeast Asian patients: Detection by the Elecsys ® HBsAg II assay. Journal of Clinical Virology 2018; 103: 48 doi: 10.1016/j.jcv.2018.04.005
|
23 |
Julien Marlet, Clément Lier, Emmanuelle Roch, Alain Moreau, Benjamin Combe, Lynda Handala, Sandrine Lefeuvre, Morgan Maugey, Laure Elkrief, Louis d’Alteroche, Pascal Potier, Denys Brand, Catherine Gaudy-Graffin. Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure. Antiviral Research 2021; 192: 105106 doi: 10.1016/j.antiviral.2021.105106
|
24 |
Julie Joseph, Grace Sandel, Ratuja Kulkarni, Reem Alatrash, Bobby Brooke Herrera, Pooja Jain. Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Pathogens 2023; 13(1): 14 doi: 10.3390/pathogens13010014
|
25 |
Pilar Nannini, Etienne M Sokal. Hepatitis B: changing epidemiology and interventions. Archives of Disease in Childhood 2017; 102(7): 676 doi: 10.1136/archdischild-2016-312043
|
26 |
Mikael Gencay, Marion Vermeulen, Dionysis Neofytos, Gaston Westergaard, Stephan Pabinger, Albert Kriegner, Anja Seffner, Peter Gohl, Kirsten Huebner, Markus Nauck, Wolfgang E. Kaminski. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay. Journal of Clinical Virology 2018; 101: 38 doi: 10.1016/j.jcv.2018.01.011
|
27 |
Tong Wang, Dawei Cui, Shaoming Chen, Xujian Xu, Changgui Sun, Yuzhu Dai, Jun Cheng. Analysis of clinical characteristics and S gene sequences in chronic asymptomatic HBV carriers with low-level HBsAg. Clinics and Research in Hepatology and Gastroenterology 2019; 43(2): 179 doi: 10.1016/j.clinre.2018.08.015
|
28 |
Jing-Hua Fan, Xiao Li, Yang Tang, Xin Lai, Xi Li, Liang Zhang, Tai-Cheng Zhou, Jia Wei. Molecular Characterization of Coexistence of HBsAg and Anti-HBs in a Patients Infected with HBV Genotype I. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.81740
|
29 |
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World Journal of Gastroenterology 2019; 25(26): 3299-3312 doi: 10.3748/wjg.v25.i26.3299
|
30 |
Takwa Mohamed, Sabah Sayed, Akram Salah, Essam Halim Houssein. Integrating Meta-Heuristics and Machine Learning for Real-World Optimization Problems. Studies in Computational Intelligence 2022; 1038: 225 doi: 10.1007/978-3-030-99079-4_9
|
31 |
Mahua Sinha, Keerthana Sundar, C. S. Premalata, Vikas Asati, Alka Murali, Akhilesh Kumar Bajpai, Sravanthi Davuluri, Kshitish K. Acharya, K. C. Lakshmaiah, Govind Babu K., Linu A. Jacob, Dharam Nandan, Dinesh Velayutham, Sibnarayan Datta, R. S. Jayshree. Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-51157-1
|
32 |
Maria V. Konopleva, Maxim S. Belenikin, Andrei V. Shanko, Alexey I. Bazhenov, Sergei A. Kiryanov, Tatyana A. Tupoleva, Maria V. Sokolova, Alexander V. Pronin, Tatyana A. Semenenko, Anatoly P. Suslov. Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies. Diagnostics 2021; 11(6): 969 doi: 10.3390/diagnostics11060969
|
33 |
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic. Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies. Pathogens 2024; 13(1): 46 doi: 10.3390/pathogens13010046
|
34 |
Wonderful T. Choga, Motswedi Anderson, Edward Zumbika, Sikhulile Moyo, Tshepiso Mbangiwa, Bonolo B. Phinius, Pinkie Melamu, Mukendi K. Kayembe, Ishmael Kasvosve, Theresa K. Sebunya, Jason T. Blackard, Max Essex, Rosemary M. Musonda, Simani Gaseitsiwe. Molecular characterization of hepatitis B virus in blood donors in Botswana. Virus Genes 2019; 55(1): 33 doi: 10.1007/s11262-018-1610-z
|
35 |
Hao Wang, Min Wang, Jieting Huang, Ru Xu, Qiao Liao, Zhengang Shan, Yourong Zheng, Xia Rong, Xi Tang, Tingting Li, Wenjing Wang, Chengyao Li, Yongshui Fu. Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection. Journal of Viral Hepatitis 2020; 27(9): 915 doi: 10.1111/jvh.13309
|
36 |
Müge Özgüler, Murat Sayan. Could Resistant and Escape Variants of Hepatitis B Virus Be a Problem in the future?. Future Virology 2018; 13(3): 171 doi: 10.2217/fvl-2017-0144
|
37 |
Seyed Y. Hosseini, Neda Sanaei, Mohamad-Reza Fattahi, Seyed A. Malek-Hosseini, Jamal Sarvari. Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients. Annals of Hepatology 2019; 18(4): 640 doi: 10.1016/j.aohep.2018.12.006
|
38 |
Leticia Bucio-Ortiz, Karina Enriquez-Navarro, Angélica Maldonado-Rodríguez, Jesús Torres-Flores, Ana Cevallos, Mauricio Salcedo, Rosalia Lira. Occult Hepatitis B Virus Infection in Hepatic Diseases and Its Significance for the WHO’s Elimination Plan of Viral Hepatitis. Pathogens 2024; 13(8): 662 doi: 10.3390/pathogens13080662
|
39 |
M.A. Rodgers, A.S. Vallari, B. Harris, J. Yamaguchi, V. Holzmayer, K. Forberg, M.G. Berg, J. Kenmenge, C. Ngansop, B. Awazi, D. Mbanya, L. Kaptue, C. Brennan, G. Cloherty, N. Ndembi. Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon. Virology 2017; 504: 141 doi: 10.1016/j.virol.2017.01.008
|
40 |
Mariia Logoida, Pavol Kristian, Andrea Schreiberova, Patrícia Denisa Lenártová, Veronika Bednárová, Elena Hatalová, Ivana Hockicková, Sylvia Dražilová, Peter Jarčuška, Martin Janičko, Štefan Porhinčák, Monika Halánová. Comparison of Two Diagnostic Methods for the Detection of Hepatitis B Virus Genotypes in the Slovak Republic. Pathogens 2021; 11(1): 20 doi: 10.3390/pathogens11010020
|
41 |
Stefan Schlabe, Kathrin van Bremen, Souhaib Aldabbagh, Dieter Glebe, Corinna M Bremer, Tobias Marsen, Walter Mellin, Veronica Di Cristanziano, Anna M Eis-Hübinger, Ulrich Spengler. Hepatitis B virus subgenotype F3 reactivation with vaccine escape mutations: A case report and review of the literature. World Journal of Hepatology 2018; 10(7): 509-516 doi: 10.4254/wjh.v10.i7.509
|
42 |
Caterina Sagnelli, Evangelista Sagnelli. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World Journal of Clinical Infectious Diseases 2019; 9(2): 11-22 doi: 10.5495/wjcid.v9.i2.11
|
43 |
Xiliang Zou, Hu Li, Mingli Peng, Ren Hong, Hongmei Xu, Peng Hu, Min Chen. Deep Sequencing Reveals the Characteristics of Hepatitis B Virus (HBV) S Region in Vertical Transmission and the Influence of Mutations on Vaccination Failure. Hepatitis Monthly 2019; 19(8) doi: 10.5812/hepatmon.90964
|
44 |
Ingrid de Campos Albuquerque, Marinilde Teles Sousa, Max Diego Cruz Santos, Jomar Diogo Costa Nunes, Maria Josélia Diniz Moraes, Michele Soares Gomes‐Gouvêa, João Renato Rebelo Pinho, Flair José Carrilho, Lena Maria Barros Fonseca, Adalgisa de Sousa Paiva Ferreira. Mutation in the S gene a determinant of the hepatitis B virus associated with concomitant HBsAg and anti‐HBs in a population in Northeastern Brazil. Journal of Medical Virology 2017; 89(3): 458 doi: 10.1002/jmv.24653
|
45 |
Khalid Abdallah Enan, Claudia Minosse, Abdel Rahim Mohammed El Hussein, Marina Selleri, Emanuela Giombini, Maria Rosaria Capobianchi, Isam Mohamed Elkhidir, Mohamed Omer Mustafa, Osama Mohamed Khair, Dina Ahamed Hassan, Anna Rosa Garbuglia. Analysis of hepatitis B virus-mixed genotype infection by ultra deep pyrosequencing in Sudanese patients, 2015–2016. Infection 2019; 47(5): 793 doi: 10.1007/s15010-019-01306-5
|
46 |
Shahrzad Shoraka, Seyed Mahdi Hosseinian, Ayda Hasibi, Amir Ghaemi, Seyed Reza Mohebbi. The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213145
|
47 |
Changtai Wang, Shu Yu, Yafei Zhang, Min Zhang, Liying Lv, Cheng Huang, Xu Li, Jun Li, Zhenhua Zhang. Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7255
|
48 |
Siping Li, Mingyu Xie, Wenrui Li, Qi Peng, Baimao Zhong, Xiaomei Lu, Qiang Ma. Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China. Archives of Virology 2017; 162(10): 2949 doi: 10.1007/s00705-017-3437-7
|
49 |
Shuxiang Wu, Shuangshuang Ye, Xiaohan Lin, Yan Chen, Yi Zhang, Zhentang Jing, Wei Liu, Wannan Chen, Xinjian Lin, Xu Lin. Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling. Cancer Letters 2021; 499: 175 doi: 10.1016/j.canlet.2020.11.032
|
50 |
Sajini Souda, Julius C. Mwita, Francesca Cainelli, Naledi B. Mannathoko, Motswedi Anderson, Sikhulile Moyo. Seroprevalence and risk factors of hepatitis B, C and D virus infection amongst patients with features of hepatitis in a referral hospital in Botswana: A cross-sectional study. Southern African Journal of Infectious Diseases 2021; 36(1) doi: 10.4102/sajid.v36i1.275
|
51 |
Jolynne Mokaya, Tetyana I. Vasylyeva, Eleanor Barnes, M. Azim Ansari, Oliver G. Pybus, Philippa C. Matthews. Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations. Journal of Viral Hepatitis 2021; 28(8): 1110 doi: 10.1111/jvh.13525
|
52 |
Yaseen I. Mamoori, Ibrahim A. Ahmed, Ayhan R. Mahmood, Safaa A. Al-Waysi, Ahmed Majeed Al-Shammari. Full-Length Genome Sequencing and Analysis of Hepatitis B Viruses Isolated from Iraqi Patients. International Journal of Microbiology 2024; 2024: 1 doi: 10.1155/2024/6826495
|
53 |
Lihong Shen, Yun Zhang, Min Shi, Lijia Shao, Shengchun Feng, Weiting Li, Zhonggang Fang, Jun Yin, Tinghua Li. Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay. Journal of Medical Virology 2024; 96(7) doi: 10.1002/jmv.29817
|
54 |
Houda Chaouch, Stefania Taffon, Umbertina Villano, Michele Equestre, Roberto Bruni, Manel Belhadj, Naila Hannachi, Mahjoub Aouni, Amel Letaief, Anna Rita Ciccaglione. Naturally Occurring Surface Antigen Variants of Hepatitis B Virus in Tunisian Patients. Intervirology 2016; 59(1): 36 doi: 10.1159/000445894
|
55 |
Fei Chen, Carl Freyer, Lan Gong, Amany Zekry. Gastrointestinal Diseases and their Associated Infections. 2019; : 41 doi: 10.1016/B978-0-323-54843-4.00004-0
|
56 |
Zainab Usman, Hrvoje Mijočević, Hadi Karimzadeh, Martin Däumer, Mamun Al‐Mathab, Michel Bazinet, Dmitrij Frishman, Andrew Vaillant, Michael Roggendorf. Kinetics of hepatitis B surface antigen quasispecies during REP 2139‐Ca therapy in HBeAg‐positive chronic HBV infection. Journal of Viral Hepatitis 2019; 26(12): 1454 doi: 10.1111/jvh.13180
|
57 |
YanMin Chen, Yin Bai, XiaoChen Guo, WenFei Wang, Qi Zheng, FuXiang Wang, Dejun Sun, DeShan Li, GuiPing Ren, JieChao Yin. Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library. Biologicals 2016; 44(4): 271 doi: 10.1016/j.biologicals.2016.05.003
|
58 |
Serkan Aydemir, Mustafa Taner Yildirmak, Murat Sayan, Süheyla Atak, Mehmet Kucuk. A chronic hepatitis B patient infected with HBsAg diagnostic-escape strain in the presence of anti-HBs positivity. Revista Romana de Medicina de Laborator 2019; 27(4): 421 doi: 10.2478/rrlm-2019-0038
|
59 |
Forough Golsaz-Shirazi, Mohammad Mehdi Amiri, Samira Farid, Motahareh Bahadori, Felix Bohne, Sebastian Altstetter, Lisa Wolff, Tohid Kazemi, Jalal Khoshnoodi, Mohammad Hojjat-Farsangi, Michael Chudy, Mahmood Jeddi-Tehrani, Ulrike Protzer, Fazel Shokri. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg). Antiviral Research 2017; 144: 153 doi: 10.1016/j.antiviral.2017.06.013
|
60 |
Fareed Ghulam, Noval Zakaria, Muhammad Ibrahim Majeed, Faisal Ismail. Viral Hepatitis - The Road Traveled and the Journey Remaining. Hepatic Medicine: Evidence and Research 2022; : 13 doi: 10.2147/HMER.S352568
|
61 |
Motswedi Anderson, Thabo Mangogola, Bonolo B. Phinius, Gorata Mpebe, Christopher O. Aimakhu, Wonderful T. Choga, Basetsana Phakedi, Lynnette N. Bhebhe, Doreen Ditshwanelo, Kabo Baruti, Linda Mpofu-Dobo, Lebogang Othusitse, Tsholofelo Ratsoma, Tendani Gaolathe, Joseph Makhema, Roger Shapiro, Shahin Lockman, Sikhulile Moyo, Simani Gaseitsiwe. Hepatitis B Virus Prevalence among HIV-Uninfected People Living in Rural and Peri-Urban Areas in Botswana. Microorganisms 2024; 12(6): 1207 doi: 10.3390/microorganisms12061207
|
62 |
Hao Zheng, Yange Lang, Jing Yu, Zhenwei Han, Bin Chen, Yefu Wang. Affinity binding of aptamers to agarose with DNA tetrahedron for removal of hepatitis B virus surface antigen. Colloids and Surfaces B: Biointerfaces 2019; 178: 80 doi: 10.1016/j.colsurfb.2019.02.040
|
63 |
Jie Wang, Jing Qiu, Yinwei Zhu, Hui Zhou, Lugang Yu, Yi Ding, Lige Zhang, Zhirong Guo, Chen Dong. Molecular evolution of hepatitis B vaccine escape variants in China, during 2000–2016. Vaccine 2017; 35(43): 5808 doi: 10.1016/j.vaccine.2017.09.030
|
64 |
Shahin Aghamiri, Ali Jafarpour, Mohammad Mahmoudi Gomari, Jaber Ghorbani, Masoumeh Rajabibazl, Zahra Payandeh. siRNA nanotherapeutics: a promising strategy for anti‐HBV therapy. IET Nanobiotechnology 2019; 13(5): 457 doi: 10.1049/iet-nbt.2018.5286
|
65 |
Zeineb Belaiba, Kaouther Ayouni, Mariem Gdoura, Wafa Kammoun Rebai, Henda Touzi, Amel Sadraoui, Walid Hammemi, Lamia Yacoubi, Salwa Abdelati, Lamine Hamzaoui, Mohamed Msaddak Azzouz, Anissa Chouikha, Henda Triki. Whole genome analysis of hepatitis B virus before and during long-term therapy in chronic infected patients: Molecular characterization, impact on treatment and liver disease progression. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1020147
|
66 |
Chinyere Constance Ezemba, Oluchi Judith Osuala, Victor O. Etikudike, Seto Charles Ogunleye, Paschal Ikeobi Ezemba, Oladunjoye Iyiola, Arinze Steven Ezemba, Ezeigwe Chidinma Dominica, Ezeh Chigozie Nicodemus Iloabuchi, Anakwenze Nonyelum Vivian, Akinsuyi Oluwamayowa. Biochemical and Molecular Pharmacology in Drug Discovery. 2024; : 515 doi: 10.1016/B978-0-443-16013-4.00025-7
|
67 |
Haiyan Li, Fuchu Qian, Weihua Zou, Fang Jin, Dongli Li, Yaqin Zhang. Seroprevalence and mutations in the major hydrophilic region of hepatitis B virus among pregnant women in Huzhou, China. Transactions of The Royal Society of Tropical Medicine and Hygiene 2022; 116(9): 874 doi: 10.1093/trstmh/trac040
|